NEW HAVEN, Conn.--(BUSINESS WIRE)--Rib-X Pharmaceuticals, Inc., a development-stage antibiotics company with a broad product pipeline based on its innovative discovery platform, announced today that Erin Duffy, Ph.D., Vice President of Discovery Research, will be a keynote speaker at the 13th Annual Superbugs & Superdrugs Conference taking place March 16-17, 2011 in London, UK. Dr. Duffy’s presentation, “Unique Molecular Insights for Designing New Broad-Spectrum Antibiotics,” will highlight the crystallography platform and the computational design capabilities of Rib-X’s anti-infective drug discovery engine. The presentation will be held at 2:10 PM GMT on Thursday, March 17, 2011.
